Malnutrition and sarcopenia in liver cirrhosis: Indian expert opinion perspective on screening and managements
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242977Keywords:
Branched chain amino acids, Malnutrition, Sarcopenia, Nutritional assessment, Liver frailty indexAbstract
Malnutrition and sarcopenia in Liver cirrhosis led to poor outcomes, complications, quality-of-life and increased mortality. This review discusses the prevalence of malnutrition and causative factors from an Indian patient and clinician perspective, nutritional assessment strategies, and management of malnutrition and sarcopenia. A group of experts discussed the dietary and lifestyle factors leading to malnutrition, screening tools and management algorithms to assess severity of malnutrition, and imaging modalities for diagnosing sarcopenia. They discussed the lack of routine screening in cirrhotic patients and advocated the use of quick and practical screening tools such as hand grip strength (HGS), gait speed, and body mass index (BMI) in clinical settings for early assessment of nutritional status and sarcopenia. Following screening and diagnosis of nutritional deficiencies, a comprehensive nutritional management plan consisting of adequate dietary protein and caloric intake, along with multivitamin and BCAA supplementation is recommended and has shown better clinical outcomes. Suitable screening and management strategies were considered essential to improve prognosis of cirrhotic patients.
Metrics
References
Allen SL, Quinlan JI, Dhaliwal A, Armstrong MJ, Elsharkawy AM, Greig CA, et al. Sarcopenia in chronic liver disease: mechanisms and countermeasures. Am J Gastrointest Liver Physiol. 2021;320:241-57.
Shah NJ, Royer A, John S. Acute liver failure. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2023. Available at: https://www.ncbi.nlm.nih.gov. Accessed on 17 May 2024.
Das J. Liver disease: managing the complications. Pharm J. 2011. Available at: https://pharmaceutical-journal.com/article/ld/liver-disease. Accessed on 17 May 2024.
Sharma A, Nagalli S. Chronic liver disease. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL):2024. Available at: https://www.ncbi.nlm.nih.gov.
Meyer F, Bannert K, Wiese M, Esau S, Sautter LF, Ehlers L, et al. Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis. Int J Mol Sci 2020;21:5357.
Zhou W-C, Zhang Q-B, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014;20:7312-24.
Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis. BMC Med. 2014;12:145. doi: 10.1186/s12916-014-0145-y.
Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol 2019;70:151-71.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol 2023;79:516-37.
Mukherjee PS, Vishnubhatla A, Amarapurkar DN, Das K, Sood A, Chawla YK, et al. Etiology and mode of presentation of chronic liver diseases in India: a multi centric study. PLoS One 2017;12:e0187033. doi: 10.1371/journal.pone.0187033.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23.
Bémeur C, Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol 2014;4:141-50.
Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC. Nutrition in chronic liver disease: Consensus of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143.
Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in patients with liver cirrhosis. Nutrients 2021;13:540. doi: 10.3390/nu13020540.
Bémeur C, Desjardins P, Butterworth RF. Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. J Nutr Metab 2010;2010:489823.
Müller MJ, Böttcher J, Selberg O, Weselmann S, Böker KH, Schwarze M, et al. Hypermetabolism in critically stable patients with liver cirrhosis. Am J Clin Nutr. 1999;69:1194-201.
Chang KV, Chen JD, Wu WT, Huang KC, Hsu CT, Han DS. Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer. 2018;7:90-103.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412-23.
Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLoS One. 2017;12:186990.
Thyloor KS, Sharma S, Kumar M, Ghuman SS, Arora A, Ranjan P. A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis. J Clin Exp Hepatol. 2023;13(6):946-954.
Gajula U, Murugan N. Assessment of sarcopenia in patients with chronic liver disease. J Clin Exp Hepatol. 2018;8:67.
Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Ailment Pharmacol Ther. 2020;51:64-77.
Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36:49-64.
Merli M, Berzigotti A, Zelber-Sagi S, Dasarathy S, Montagnese S, Genton L, et al. EASL clinical practice guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-93.
Molfino A, Johnson S, Medici V. The challenges of nutritional assessment in cirrhosis. Curr Nutr Rep. 2017;6:274-80.
Mendenhall CL, Andersen S, Weesner RE, Goldberg SJ, Crolic KA. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med. 1984;76:211-22.
Borhofen SM, Gerner C, Lehmann J, Fimmers R, Görtzen J, Hey B, et al. The Royal Free Hospital-Nutritional Prioritizing Tool is an independent predictor of deterioration of liver function and survival in cirrhosis. Dig Dis Sci. 2016;61:1735-43.
McFarlane M, Hammond C, Roper T, Mukarati J, Ford R, Burrell J, et al. Comparing assessment tools for detecting undernutrition in patients with liver cirrhosis. Clin Nutr ESPEN. 2018;23:156-61.
Tandon P, Raman M, Mourtzakis M, Merli M. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology. 2017;65:1044-57.
Anand A, Saraya A. Assessment of sarcopenia in chronic liver disease: Indian perspective. Clin Liver Dis (Hoboken). 2021;18:164-7.
Sinclair M, Chapman B, Hoermann R, Angus PW, Testro A, Scodellaro T, et al. Handgrip strength adds more prognostic value to the model for end-stage liver disease score than imaging based on measures of muscle mass in men with cirrhosis. Liver Transpl. 2019;25:1480-7.
Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564-74.
Plauth M. Basics in clinical nutrition: nutritional support in liver disease. e-SPEN. 2010:104-6.
Plank LD, Gane EJ, Peng S, Muthu C, Mathur S, Gillanders L, et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology. 2008;48:557-66.
Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, et al. A North American expert opinion statement on sarcopenia in liver transplantation. Hepatology. 2019;70:1816-29.
Hiramatsu A, Aikata H, Uchikawa S, Ohya K, Kodama K, Nishida Y, et al. Levocarnitine use is associated with improvement in sarcopenia in patients with liver cirrhosis. Hepatol Commun. 2019;3:348-55.
Sinclair M, Grossmann M, Hoermann R, Angus PW, Gow PJ. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomized controlled trial. J Hepatol. 2016;65:906-13.
Calder PC. Immunonutrition in surgical and critically ill patients. Br J Nutr. 2007;98:133-9.
Eghtesad S, Poustchi H, Malekzadeh R. Malnutrition in liver cirrhosis: the influence of protein and sodium. Middle East J Dig Dis. 2013;5:65-75.
Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World J Gastroenterol. 2013;19:7620-9.
Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind randomized trial. Gastroenterology. 2003;124:1792-801.
Park JG, Tak WY, Park SY, Kweon YO, Jang SY, Lee YR, et al. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicentre, retrospective, observational, cohort study. Medicine (Baltimore). 2017;96:65-80.
Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416-23.
Tejavath AS, Mathur A, Nathiya D, Singh P, Raj P, Suman S, et al. Impact of branched chain amino acid on muscle mass, muscle strength, physical performance, combined survival, and maintenance of liver function changes in laboratory and prognostic markers on sarcopenic patients with liver cirrhosis (BCAAS study): A randomized clinical trial. Front Nutr. 2021;8:7157-95.
Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:19-39.
Bhargava V, Sarda K, Das S. Current practice of branched chain amino acids administration in patients with liver cirrhosis: a physician survey. J Clin Diag Res. 2021;15:44-8.
Downloads
Published
How to Cite
Issue
Section
